GoodRx Holdings Inc (NASDAQ:GDRX) shares, rose in value, with the stock price up by 2.07% to the previous day’s close as strong demand from buyers drove the stock to $6.91.
Actively observing the price movement in the last trading, the stock closed the session at $6.77. The value of beta (5-year monthly) was 1.44. Referring to stock’s 52-week performance, its high was $9.37, and the low was $4.14. On the whole, GDRX has fluctuated by 4.38% over the past month.
With the market capitalization of GoodRx Holdings Inc currently standing at about $2.73 billion, investors are eagerly awaiting this quarter’s results, scheduled for May 08, 2024 – May 13, 2024. As a result, investors might want to see an improvement in the stock’s price before the company announces its earnings report. Analysts are projecting the company’s earnings per share (EPS) to be $0.07, which is expected to increase to $0.12 for fiscal year $0.35 and then to about $0.45 by fiscal year 2025. Data indicates that the EPS growth is expected to be 25.00% in 2025, while the next year’s EPS growth is forecast to be 28.60%.
Analysts have estimated the company’s revenue for the quarter at $196.01 million, with a low estimate of $195 million and a high estimate of $197.45 million. According to the average forecast, sales growth in current quarter could jump up 6.50%, compared to the corresponding quarter of last year. Wall Street analysts also predicted that in 2025, the company’s y-o-y revenues would reach $800.8 million, representing an increase of 6.70% from the revenues reported in the last year’s results.
Revisions could be a useful indicator to get insight on short-term price movement; so for the company, there were no upward and no downward review(s) in last seven days. We see that GDRX’s technical picture suggests that short-term indicators denote the stock is a 50% Buy on average. However, medium term indicators have put the stock in the category of 100% Buy while long term indicators on average have been pointing out that it is a 50% Buy.
The stock’s technical analysis shows that the PEG ratio is about 0, with the price of GDRX currently trading nearly -2.32% and 4.86% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 48.67, while the 7-day volatility ratio is showing 4.36% which for the 30-day chart, stands at 5.34%. Furthermore, GoodRx Holdings Inc (GDRX)’s beta value is 1.44, and its average true range (ATR) is 0.40.
A comparison of GoodRx Holdings Inc (GDRX) with its peers suggests the former has fared considerably weaker in the market. GDRX showed an intraday change of 2.07% in last session, and over the past year, it grew by 7.30%%.
Data on historical trading for GoodRx Holdings Inc (NASDAQ:GDRX) indicates that the trading volumes over the past 10 days have averaged 1.79 million and over the past 3 months, they’ve averaged 1.72 million. According to company’s latest data on outstanding shares, there are 92.36 million shares outstanding.
Nearly 80.61% of GoodRx Holdings Inc’s shares belong to company insiders and institutional investors own 13.27% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 9.69 million shares as on Feb 29, 2024, resulting in a short ratio of 6.49. According to the data, the short interest in GoodRx Holdings Inc (GDRX) stood at 2.45% of shares outstanding as of Feb 29, 2024; the number of short shares registered in Jan 31, 2024 reached 9.74 million. The stock has risen by 3.13% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the GDRX stock heading into the next quarter.
